A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CdA / cladribine

[Related PubMed/MEDLINE]
Total Number of Papers: 28
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CdA  (>> Co-occurring Abbreviation)
Long Form:   cladribine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Dissection of the bone marrow microenvironment in hairy cell leukaemia identifies prognostic tumour and immune related biomarkers. BM, HCL
2020 Cladribine modifies functional properties of microglia. Arg1, CNS, CSF, dCK, IL, iNOS, LPS, qPCR, TNF, TNFR2
2019 The role of cladribine in acute myeloid leukemia: an old drug up to new tricks. AML, R/R
2017 Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis. CAde, CLCR, CLNR, CLR, IFN, MS, PK
2017 sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-alpha therapy. HCL, IFN-alpha, IL28B, sIL-2R
2014 Revisiting the role of cladribine in acute myeloid leukemia: an improvement on past accomplishments or more old news? AML, CR, ND, RR
2012 Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells. dCK, NA
2010 Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders. CD, FdA
2010 Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma. DIGE, ER, FdA
10  2008 Pharmacokinetics of cladribine in a rat model following subcutaneous and intra-arterial injections. ---
11  2007 Development and validation of a sensitive and specific HPLC assay of cladribine for pharmacokinetics studies in rats. ---
12  2007 Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs. Dm-dNK, dNK, NAs
13  2005 Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy. aa, CAMD, Cyd, dA, dC, dCK, dG
14  2005 Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells. ara-C, CI, dCK, DRI
15  2004 2-Chloro-2'-deoxyadenosine synergistically enhances azidothymidine cytotoxicity in azidothymidine resistant T-lymphoid cells. ara-C, AZT, CI, DRI, TK
16  2001 Identification and characterization of human deoxyguanosine kinase cDNA fragments. ara-G
17  2001 Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide. 5'-NT, dCK, dCTP, topo
18  2000 Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study. Flu
19  2000 Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs. ara-A, ATRA, DCF, Flu
20  1999 Evaluation of purine and pyrimidine analogues in human tumor cells from patients with low-grade lymphoproliferative disorders using the FMCA. ALL, AML, ara-C, FDA, FMCA, NHL
21  1998 Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. 5-FU, FITC
22  1998 Cladribine for untreated or early low-grade non-Hodgkin's lymphoma. LG-NHL
23  1998 Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines. dNTPs, NTPs
24  1998 Pharmacokinetics of cladribine in plasma and its 5'-monophosphate and 5'-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia. AUC, CdAMP, CdATP
25  1998 Relationship between cladribine (CdA) plasma, intracellular CdA-5'-triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL). AUC, CdAMP, CdATP, CdATP, CLL, dCK
26  1998 Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients. CR, HCL, NCI, PR
27  1997 Intermittent infusion of cladribine (CdA) in previously treated patients with low-grade non-Hodgkin's lymphoma. LG-NHL
28  1993 Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro. ---